News Preview
Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline Transcript
Arrowhead Pharmaceuticals, Inc. (ARWR) presented interim results of its ARO-MAPT clinical trial and discussed its TRiM CNS delivery platform. The company's pipeline focuses on treating neurological diseases.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.